The intraoperative neuromonitoring market share in the US will post an incremental growth of USD 1.15 billion, progressing at a CAGR of 10.13% during the forecast period. The increasing number of surgeries that require IONM will offer immense growth opportunities to market vendors. The intraoperative neuromonitoring market in the US is fragmented, and the vendors are deploying growth strategies such as low-pricing strategies and strengthening the local customer base to compete in the market.
Technavio’s report on “Intraoperative Neuromonitoring Market in the US by Application and Type - Forecast and Analysis 2022-2026” provides a detailed analysis of the prevalent market forces, trends, and challenges likely to impact the market in focus.
The intraoperative neuromonitoring market in the US is segmented by type (insourced IONM and outsourced IONM) and application (orthopedic and neuro surgeries, cardiovascular surgeries, ENT surgeries, and other surgeries).
The growth of the intraoperative neuromonitoring market size in the US by the insourced IONM segment will be significant during the forecast period. The growth of the segment is attributed to the factors such as increasing awareness of the benefits of insourced IONM, the rising number of big hospitals, and the surging surgical volumes in large hospitals.
The increasing number of surgeries that require IONM will directly influence the intraoperative neuromonitoring market in the US. In addition, the increasing number of acquisitions is one of the major intraoperative neuromonitoring market trends in the US that will positively impact the market growth. However, factors such as the high cost of IONM devices and procedures will hamper the intraoperative neuromonitoring market in the US growth.
The market is fragmented due to the presence of several players. Some of the major intraoperative neuromonitoring market vendors in the US are Accurate Neuromonitoring LLC, Cadwell Industries Inc., Computational Diagnostics Inc., IntraNerve Neuroscience Holdings LC, Medtronic Plc, Natus Medical Inc., NeuroMonitoring Technologies Inc., Nihon Kohden Corp., NuVasive Inc., and SpecialtyCare Inc.
To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions.
Download the Free PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth.
Precise market size estimation during the forecast period 2022-2026.
CAGR of the intraoperative neuromonitoring market in the US forecast during 2022-2026.
Market-level data on units, average selling prices, and values of the intraoperative neuromonitoring market share in the US.
Prediction of the upcoming trends, drivers, and factors that challenge the growth of the intraoperative neuromonitoring market in the US.
Intraoperative neuromonitoring industry growth across the US.